Group 1 - The company, Estun, plans to globally offer 96.78 million H-shares, with 9.678 million shares available in Hong Kong and 87.102 million shares for international offering, aiming to raise up to HKD 1.645 billion before the greenshoe option [1] - The subscription period for the shares is set from February 27 to March 4, 2026, with a price range between HKD 15.36 and HKD 17, and an entry fee of HKD 3,434.29 for a minimum lot of 200 shares [1] - Estun has established cornerstone investment agreements with several investors, who will subscribe for shares amounting to approximately USD 66.91 million at the offer price [1] Group 2 - Estun is a leading Chinese industrial robot company that provides industrial robots, smart manufacturing systems, and automation core components to various manufacturing sectors, including automotive and heavy industries [1] - According to Frost & Sullivan, Estun has maintained the top position in domestic industrial robot shipments among local companies for several consecutive years and achieved a historic milestone in the first half of 2025 by surpassing foreign brands in domestic market shipments [1] - The cornerstone placement indicates strong confidence from investors in the company's business prospects and is expected to enhance the company's image due to the investors' industry experience [2]

Major Events - 德视佳 (01846) plans to acquire FYEO Europe B.V., a leading refractive surgery company in the Netherlands, with a significant investment [1] - 美格智能 (03268) is set to launch an IPO from February 27 to March 5, aiming to globally offer 35 million H-shares [1] - 埃斯顿 (02715) will also conduct an IPO from February 27 to March 4, with a global offering of 96.78 million H-shares [1] - 兆威机电 (02692) is expected to list on March 9 after its IPO from February 27 to March 4 [1] - 优乐赛共享 (02649) plans to globally offer 20.336 million H-shares during its IPO from February 27 to March 4 [1] - 蔚来-SW (09866) subsidiary has signed a final agreement for a 2.257 billion RMB investment [1] - 贪玩 (09890) has secured exclusive operation rights for the game "天龙八部2：飞龙战天" and invested in game developer 上海阅龙 [1] - 贝康医疗-B (02170) received a medical device registration certificate from the National Medical Products Administration for its Geri embryo culture solution [1] Operating Performance - 百度集团-SW (09888) reported Q4 revenue of 32.7 billion RMB, a 5% quarter-on-quarter increase, with "萝卜快跑" total order volume growing over 200% year-on-year [2] - 香港交易所 (00388) announced a 2025 full-year profit attributable to shareholders of 17.754 billion HKD, a 36% year-on-year increase [2] - 新鸿基地产 (00016) reported a mid-year profit attributable to shareholders of 10.247 billion HKD, a 36.21% year-on-year growth [2] - 银河娱乐 (00027) posted an annual profit attributable to shareholders of 10.7 billion HKD, a 22% increase year-on-year [2] - 周大福创建 (00659) reported a mid-year profit attributable to shareholders growing 15% year-on-year to 1.3343 billion HKD [2] - 百济神州 (06160) showed strong growth in 2025 with an adjusted net profit of approximately 918 million USD, returning to profitability [2] - 再鼎医药 (09688) reported total revenue of 460.2 million USD in 2025, a 15% year-on-year increase, with significant progress in its global innovation pipeline [2] - 百奥赛图-B (02315) released a 2025 annual performance report showing a net profit of 173 million RMB, a 416.37% year-on-year increase [2] - 康希诺生物 (06185) reported a 2025 annual performance report with a net profit of 27.827 million RMB, returning to profitability [2] - 中电控股 (00002) announced an annual profit attributable to shareholders of 10.468 billion HKD, a 10.85% year-on-year decrease [2] - 正力新能 (03677) expects a net profit increase of up to eight times in 2025, estimated at 680 to 820 million RMB, significantly exceeding market expectations [2] - 至源控股 (00990) issued a profit warning, anticipating a 126% year-on-year increase in net profit to approximately 840 million RMB in 2025 [2]

Core Viewpoint - Estun, a pioneer in China's industrial robot industry, is set to become the first industrial robot company to achieve dual listing in Hong Kong and mainland China, with plans to use the raised funds for global capacity expansion, enhancing overseas supply chain collaboration, strengthening core technology R&D, and repaying existing debts [1] Group 1: Global Expansion and Strategic Acquisitions - Estun has embedded itself deeply into the global manufacturing landscape through capital operations and physical construction, differentiating itself from competitors that primarily rely on export trade [2] - The company has made strategic acquisitions to enhance its core technologies, including the acquisition of UK-based Trio in 2017 and Germany's Cloos in 2020, which allowed entry into high-end motion control and mid-to-high-end arc welding robot markets [2] - Estun has established seven manufacturing bases globally, with five in China and two in Germany, and its Poland factory is expected to start production in June 2026 with an annual capacity of 15,000 units, significantly improving delivery times and supply chain responsiveness in Europe [2] Group 2: Market Position and Sales Performance - As of September 30, 2025, Estun has set up 75 service outlets globally, covering major markets in Europe, America, and Asia, with Europe being a key strategic focus [3] - In the first half of 2025, Estun surpassed foreign brands in industrial robot shipments in China, becoming the first domestic company to lead the market [3] - By 2024, Estun is projected to rank among the top five global industrial robot solution providers with a market share of 5.5%, and its share in the Chinese market has increased to 9.5%, narrowing the gap with the leading brand Fanuc [3] Group 3: Financial Performance and R&D Investment - Estun's revenue for the fiscal year 2024 is expected to be 4.009 billion yuan, remaining stable compared to 3.881 billion yuan in 2022, although it recorded a net loss of 818 million yuan due to one-time factors like impairment of intangible assets [4] - In the first three quarters of 2025, Estun achieved revenue of 3.804 billion yuan, nearing 85% of the total revenue for 2024, with an operating profit of 181 million yuan, indicating a recovery in core business profitability [5] - R&D expenditure is projected to reach 442 million yuan in 2024, with continued growth in R&D investment in the first three quarters of 2025, which is expected to strengthen the company's core competitive advantages [6] Group 4: Product Matrix and Revenue Structure - Estun's main business focuses on industrial robots and intelligent manufacturing systems, with the revenue share from these segments increasing from 73.1% in 2022 to 82.5% in the first three quarters of 2025 [7] - The company has a diverse product matrix with 96 models covering general and specialized types, with sales of industrial robots steadily increasing from 11,852 units in 2022 to 24,884 units in the first three quarters of 2025 [8] - The intelligent manufacturing systems segment has seen rapid growth, with a 33% year-on-year increase in revenue in the first three quarters of 2025, contributing to 24.4% of total revenue [7]

Core Insights - Estun, a pioneer in China's industrial robot industry, has a market capitalization of approximately 21.1 billion RMB, with a current stock price of 24.22 RMB per share. The company has established a comprehensive competitive barrier across the entire industrial chain from core components to complete robots through organic growth and strategic acquisitions since it developed its first industrial robot in 2010 [1] Group 1: Global Expansion and Strategic Positioning - Estun has embedded itself deeply into the global manufacturing landscape through capital operations and physical construction, differentiating itself from competitors that primarily rely on export trade. The company has achieved core technological advancements through precise acquisitions, including the purchase of UK-based Trio in 2017 and Germany's Cloos in 2020 [2] - The company has established seven manufacturing bases globally, with five in China and two in Germany. The upcoming Poland factory, expected to commence production in June 2026 with an annual capacity of 15,000 units, will significantly enhance delivery efficiency and supply chain responsiveness in the European market [2] Group 2: Market Performance and Competitive Position - As of September 30, 2025, Estun has set up 75 service outlets globally, covering major markets in Europe, America, and Asia. The company became the first domestic brand to surpass foreign brands in industrial robot shipments in China, achieving a market share of 9.5%, narrowing the gap with the leading brand Fanuc at 10.9% [3] - Estun ranks among the top five global industrial robot solution providers with a market share of 5.5%. The company has shipped over 105,000 industrial robots, with a product matrix covering payloads from 3 kg to 700 kg across various manufacturing sectors [3][4] Group 3: Financial Performance and Growth Indicators - Estun's revenue for the fiscal year 2024 was 4.009 billion RMB, remaining stable compared to 3.881 billion RMB in 2022. However, the company recorded a net loss of 818 million RMB due to one-time factors such as impairment of intangible assets. Excluding these non-recurring items, the company's operational profitability remains resilient [4] - In the first three quarters of 2025, Estun achieved a revenue of 3.804 billion RMB, nearing 85% of the total revenue for 2024, with an operating profit of 181 million RMB, indicating a recovery in core business profitability [5] - The company has increased its R&D expenditure to 442 million RMB in 2024, with ongoing growth in R&D investments expected to strengthen its core competitive advantages in the industry [6] Group 4: Product and Service Development - Estun's main business focuses on industrial robots and intelligent manufacturing systems, with the revenue contribution from these sectors steadily increasing from 73.1% in 2022 to 82.5% in the first three quarters of 2025. The intelligent manufacturing systems segment has seen a significant growth of 33% year-on-year [7] - The company has developed a product matrix of 96 models, widely applied in key industries such as electronics, automotive, and lithium batteries. The sales volume of industrial robots has consistently expanded, with 24,884 units sold in the first three quarters of 2025 [8] - The automation core components and motion control systems segment has seen a structural decline in revenue share, with the motion control solutions revenue share decreasing from 15.3% in 2022 to 11.7% in the first three quarters of 2025 [9]

招股书披露，2025年上半年，埃斯顿实现历史性突破，其在中国市场的工业机器人出货量首次超越外资品牌，成为本土首家登顶中国工业机器人解决方案市 场的企业。 按2024年出货量计，埃斯顿已跻身全球前五大工业机器人解决方案供应商，市场份额达5.5%；在中国市场，其份额提升至9.5%，与排名第一的发那科（市 占率10.9%）差距进一步收窄。截至2025年9月末，公司累计工业机器人出货量突破10.5万台，产品矩阵覆盖3kg至700kg负载段，合计96款机型，广泛渗透汽 车、锂电、光伏、3C电子、金属加工及工程机械等十余个核心制造领域。 在细分赛道方面，埃斯顿已形成多个具有全球竞争力的"隐形冠军"业务——按2024年出货量计，其钣金折弯机器人与光伏领域工业机器人均位列全球首位； 动力电池工业机器人在中国市场排名第一；弧焊机器人出货量位居全球第五。 作为中国工业机器人产业的开拓者，埃斯顿（002747.SZ）以当前股价24.22元人民币计算，公司总市值约为211亿元人民币。自2010年成功研制首台工业机 器人，至2025年东欧波兰生产基地的建成投产，埃斯顿通过内生性成长与战略性并购并举，已构建起涵盖核心零部件至机器人整机的 ...

智通财经APP讯，埃斯顿(002747.SZ)发布公告，公司本次全球发售H股基础发行股数为9678万股(视乎超 额配售权行使与否而定)，其中，初步安排香港公开发售967.8万股(可予重新分配)，约占全球发售总数 的10%;国际发售8710.2万股(可予重新分配及视乎超额配售权行使与否而定)，约占全球发售总数的 90%。 公司本次H股发行的价格区间初步确定为15.36港元至17港元。公司H股香港公开发售于2026年2月27日 开始，预计于2026年3月4日结束，并预计于2026年3月6日前(含当日)公布发行价格。公司本次发行的H 股预计于2026年3月9日在香港联交所挂牌并开始上市交易。 ...

智通财经APP讯，埃斯顿(002747.SZ)发布公告，公司本次全球发售H股基础发行股数为9678万股(视乎超 额配售权行使与否而定)，其中，初步安排香港公开发售967.8万股(可予重新分配)，约占全球发售总数 的10%;国际发售8710.2万股(可予重新分配及视乎超额配售权行使与否而定)，约占全球发售总数的 90%。 公司本次H股发行的价格区间初步确定为15.36港元至17港元。公司H股香港公开发售于2026年2月27日 开始，预计于2026年3月4日结束，并预计于2026年3月6日前(含当日)公布发行价格。公司本次发行的H 股预计于2026年3月9日在香港联交所挂牌并开始上市交易。 ...

股票代码：002747 股票简称：埃斯顿 公告编号：2026-008号 南京埃斯顿自动化股份有限公司 关于刊发 H 股招股说明书、H 股发行价格区间及 H 股香港公开发 售等事宜的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 南京埃斯顿自动化股份有限公司（以下简称"公司"）正在进行申请发行境 外上市外资股（H 股）并在香港联合交易所有限公司（以下简称"香港联交所"） 主板挂牌上市（以下简称"本次发行并上市"）的相关工作。 公司已于 2025 年 6 月 27 日向香港联交所递交了本次发行并上市的申请，并 于同日在香港联交所网站刊登了申请资料。具体内容详见公司 2025 年 6 月 30 日披露于《证券时报》《中国证券报》和巨潮资讯网（www.cninfo.com.cn）上的 《关于向香港联交所递交境外上市外资股（H 股）发行并上市申请并刊发申请资 料的公告》（公告编号：2025-047 号）。 2025 年 12 月 9 日，公司收到中国证券监督管理委员会（以下简称"中国证 监会"）出具的《关于南京埃斯顿自动化股份有限公司境外发行上市备案通知书》 （国 ...

公司已订立基石投资协议，据此，基石投资者已同意在若干条件的限制下，按发售价认购或促使其指定 实体认购一定数量的发售股份，该等发售股份可按总金额约6691万美元(或约5.23亿港元)认购。基于发 售价每股发售股份17.00港元(即本招股章程所载指示性发售价范围的上限)，基石投资者将认购的发售股 份总数将为3076.36万股。基石投资者包括Harvest Oriental、亨通光电国际(由亨通光电(600487.SH)全资 拥有)、Dream'ee HK Fund、至源控股(00990.HK)、Haitian Huayuan、裕祥(由网誉科技(01483.HK)全资拥 有)、前海合众投资。 公司估计，假设超额配股权未获行使，且发售价为每股H股16.18港元(即本招股章程所述的指示性价格 范围的中位数)，公司将收到约14.86亿港元的全球发售所得款项净额。根据公司的战略，公司目前计划 将这些所得款项净额用于以下用途，但可根据业务需要的变化和市场环境的变动进行调整：(i)约25.0% 将用于扩充公司的全球生产能力；(ii)约25.0%将用于在全球工业机器人产业链上下游有选择地寻求战略 联盟、投资及收购机会；(iii) ...

格隆汇2月27日丨埃斯顿(02715.HK)发布公告，公司拟全球发售9678万股H股，中国香港发售股份967.8 万股，国际发售股份8710.2万股(以上可予重新分配及视乎超额配股权行使与否而定)；2026年2月27日至 3月4日招股，预期定价日为3月5日；发售价将不超过每股发售股份17.00港元，H股的每手买卖单位将为 200股，华泰国际为独家保荐人；预期H股将于2026年3月9日开始于联交所买卖。 ...